The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Novo-Nordisk

  • NVO
  • NYSE
  • Consumer Products
  • Latest 161.87
  • Currency US$
  • Change 0.17
  • Percent Change 0.105 %
  • Volume 2,700
  • Tue Jun 18, 2013 4:02 PM EDT NYSE data delayed 15 minutes.
  • Open 162.37
  • Previous Close 161.70
  • High 163.02
  • Low 161.784
  • Bidx1 159.28
  • Askx1 160.08
  • 52-week High -- 194.44
  • 52-week Low -- 135.77
  • Beta 1.041
  • Market Cap 90,647.20M
  • EPS 7.30
  • P/E 22.17
  • Forward P/E 17.481
  • PEG 1.34
  • Annual Dividend 3.184
  • Yield 1.967

News

Financials & Calendars

Income Statement

  • Sales $14,000,650,000
  • Earnings $3,969,240,000
  • Return on Equity 61.03%

Cash Flow

  • Cash Flow --
  • Cash $1,219,150,000
  • Current Ratio 1.40

12 months ended Mar 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $11,059,360,000
  • Liabilities $5,073,200,000
  • Liabilities-to-Equity Ratio 0.85

Price Ratios

  • Price to Sales 6.47
  • Price to Book 15.14
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings May 1 n/a Aug 8 n/a
Surprises Feb 2 14.73% n/a n/a
Dividends Mar 21 $3.18 n/a n/a
Splits n/a -- n/a n/a

12 months ended Jun 19, 2013.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.

Related Securities
Symbol Type Latest % Chg

Officers

  • Lars Rebien Sorensen President and Chief Executive
  • Jesper Brandgaard Executive Vice President and C
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

NOVO ALLE DK 2880
BAGSVAERD DENMARK, G7
00000

Phone: 4544448888

lbpj@novonordisk.com
www.novonordisk.com

Ideas & Discussion

Live Discussion of NVO on StockTwits